Latest Lead News

Hamelin Gold has completed the second tranche of its share placement, issuing new shares to directors and granting options to lead managers, signaling strong backing ahead of its exploration ambitions.

Lithium Universe Limited has announced a $1.7 million capital raising via a two-tranche placement to fund the development of its Bécancour Lithium Refinery in Canada, alongside R&D initiatives and working capital needs.

betr Entertainment has unveiled a compelling all-scrip takeover offer for PointsBet, featuring an $80 million selective buy-back to provide liquidity and promising significant value creation for shareholders.

GPT Group has announced an estimated distribution of 12.0 cents per stapled security for the first half of 2025, setting the stage ahead of its interim results release in August.

North Stawell Minerals Ltd (ASX – NSM) has opened a $2.1 million non-renounceable entitlement offer to fund key gold exploration projects in Victoria. This follows a $1.5 million placement, together raising $3.6 million to advance drilling and development.

Argenica Therapeutics has won up to $1.5 million in non-dilutive government funding to support its late-stage clinical trial of ARG-007, a promising treatment for acute ischaemic stroke.

Elph Investments has secured a 92.68% stake in Engenco, making its 31-cent takeover offer unconditional and prompting the board to urge shareholders to accept before the June 27 deadline.

Neurizon Therapeutics reveals that its lead drug candidate NUZ-001 and its metabolite effectively penetrate the blood-brain barrier and reverse pathological protein aggregation linked to ALS, marking a critical step forward in neurodegenerative disease treatment.

Odyssey Gold Commitments Limited has secured $4 million through a share placement to accelerate drilling and development at its Tuckanarra Gold Project, aiming to unlock near-term production potential.

Lode Resources has announced a maiden Mineral Resource Estimate for its Webbs Consol project in New South Wales, revealing a high-grade silver equivalent resource of 32 million ounces. The estimate confirms the project's potential with strong grades and promising metallurgical recoveries.

Transurban Group has announced a 33-cent ordinary dividend for the half-year ending June 2025, offering shareholders a fully franked, no-discount dividend reinvestment plan.

Proteomics International has launched PromarkerD, a pioneering blood test that predicts diabetic kidney disease years before symptoms, marking its entry into the vast US healthcare market.